FindTrial
Sign In

Efficacy and safety of pulmicort repulas-impregnated nasal dressing after endoscopic sinus surgery

Efficacy and safety of pulmicort repulas-impregnated nasal dressing after endoscopic sinus surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011409
Enrollment
Unknown
Registered
2017-05-16
Start date
2016-07-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic rhinosinusitis with nasal polyps

Interventions

2:pulmicort repulas

Sponsors

Beijing Tongren Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 to 70 years; 2. Subjects with chronic rhinosinusitis with nasal polyps, the VAS score>3 and lund-Mackay score>4 on each side of nasal caity; 3. patients with good compliance; 4. without any contraindication of surgical operation.

Exclusion criteria

Exclusion criteria: 1. join in other drugs or medical devices clinial trials in recent 4 weeks; 2. uncontrolled systemic disease; 3. women are pregnant or breast-feeding; 4. fungal sinusitis, allergic fungal sinusitis, associated with asthma, nasal sinus tumor; 5. ongoing systemic steroid hormone therapy; 6. cystic fibrosis,primary ciliary dysfunction or Kartagener syndrome etc;

Design outcomes

Primary

MeasureTime frame
VAS;Lund-kennedy;—

Countries

China

Contacts

Public ContactBing Zhou

Beijing Tongren Hospital, Capital Medical University

entzhou@263.net+86 10 58269207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026